ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Zhuozhuo Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9604-9460; OpenAlex author ID A5090565405. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell axis in MHC-I deficient pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217620 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaoyu Liu · 1 shared paper, 2025 · strength 0.21
- Paper Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell ax… DOI 10.1016/j.canlet.2025.217620 ↗
Wenguo Cui · 1 shared paper, 2025 · strength 0.21
- Paper Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell ax… DOI 10.1016/j.canlet.2025.217620 ↗
Zhongmin Wang · 1 shared paper, 2025 · strength 0.21
- Paper Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell ax… DOI 10.1016/j.canlet.2025.217620 ↗
Chenlei Wen · 1 shared paper, 2025 · strength 0.21
- Paper Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell ax… DOI 10.1016/j.canlet.2025.217620 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.